Zobrazeno 1 - 10
of 42
pro vyhledávání: '"John T. Monyak"'
Autor:
Donald G. Vidt, Giuseppe Remuzzi, Hans-Henrik Parving, Deborah Anzalone, Dick de Zeeuw, John T. Monyak, Michael D. Cressman, Bruce A. Molitoris, Hiddo J.L. Heerspink, James R. Sowers, Valerie A. Cain
Publikováno v:
Lancet Diabetes & Endocrinology, 3(3), 181-190. ELSEVIER SCIENCE INC
Summary Background The role of lipid-lowering treatments in renoprotection for patients with diabetes is debated. We studied the renal effects of two statins in patients with diabetes who had proteinuria. Methods PLANET I was a randomised, double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a29dc7b27484451abee79e71fc992ee
https://hdl.handle.net/11370/011cb72a-f0a2-4972-b32b-7fa7b8080c3b
https://hdl.handle.net/11370/011cb72a-f0a2-4972-b32b-7fa7b8080c3b
Publikováno v:
The American Journal of Cardiology. 109:1239-1246
Patients with acute coronary syndrome are recommended for early aggressive low-density lipoprotein (LDL) cholesterol-lowering therapy. The LUNAR study compared the efficacy of rosuvastatin with that of atorvastatin in decreasing LDL cholesterol in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ab8c427ee289b933a12d38b416ce50
https://doi.org/10.1016/j.amjcard.2011.12.015
https://doi.org/10.1016/j.amjcard.2011.12.015
Publikováno v:
Alimentary Pharmacology & Therapeutics. 34:487-493
Aliment Pharmacol Ther 2011; 34: 487–493 Summary Background Erosive oesophagitis appears to be more common in white vs. nonwhite patients with gastro-oesophageal reflux disease (GERD). Aim To evaluate the association between race and erosive oesoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c42d0c40ac84a733cc6fb421dd37f9e0
https://doi.org/10.1111/j.1365-2036.2011.04736.x
https://doi.org/10.1111/j.1365-2036.2011.04736.x
Publikováno v:
Clinical Therapeutics. 33:717-725
Serum creatinine-based estimates of glomerular filtration rate (eGFR) are frequently used to identify patients with chronic kidney disease and assess cardiovascular risk both in clinical trials and in clinical practice. Although change in eGFR may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07c42935050ec47fb840cc5f24ef0b0
https://doi.org/10.1016/j.clinthera.2011.05.004
https://doi.org/10.1016/j.clinthera.2011.05.004
Publikováno v:
Journal of the American College of Cardiology. 57:1666-1675
Objectives The purpose of this study was to assess the impact on cardiovascular and adverse events of attaining low-density lipoprotein cholesterol (LDL-C) levels Background The safety and magnitude of cardiovascular risk reduction conferred by treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe7bdeb88a62bad55af5d1f5b19e861
https://doi.org/10.1016/j.jacc.2010.09.082
https://doi.org/10.1016/j.jacc.2010.09.082
Autor:
Steven G. Simonson, David C. Metz, Gerard J. Fulda, Keith M. Olsen, Mark Sostek, John T. Monyak
Publikováno v:
Current Medical Research and Opinion. 26:1141-1148
A widely held belief contends that food-induced proton pump activation is important for optimal proton pump inhibitor-induced inhibition of gastric acid secretion. This study was undertaken to assess intragastric acid control with intravenous (IV) es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8b28301e422ffd276a86af5133d6d3
https://doi.org/10.1185/03007991003694308
https://doi.org/10.1185/03007991003694308
Publikováno v:
Alimentary Pharmacology & Therapeutics. 27:483-490
Summary Background Intravenous (IV) formulations of proton pump inhibitors are effective for patients in whom oral therapy is not appropriate. Aim To compare IV esomeprazole and IV lansoprazole for the control of intragastric pH. Methods In this open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61f36950fd70ebdcea16f13d5264c289
https://doi.org/10.1111/j.1365-2036.2007.03592.x
https://doi.org/10.1111/j.1365-2036.2007.03592.x
Autor:
Chris E. Forsmark, Philippe Ruszniewski, David C. Metz, Mark Sostek, Joseph R. Pisegna, John T. Monyak
Publikováno v:
The American Journal of Gastroenterology. 102:2648-2654
To evaluate the efficacy and safety of oral esomeprazole in the control of gastric acid hypersecretion in patients with hypersecretory states.In this 12-month, open-label, multicenter study, acid output (AO) was evaluated at baseline, day 10, and mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f080cb873545098d17273490d5a3cd3
https://doi.org/10.1111/j.1572-0241.2007.01509.x
https://doi.org/10.1111/j.1572-0241.2007.01509.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 25:617-628
Summary Aim To assess the relationship between the percentage of time intragastric pH >4.0 and healing of erosive oesophagitis. Methods In this proof-of-concept study, adults with endoscopically verified Los Angeles grade C or grade D erosive oesopha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5f55499f214eda8bf99d0e84cb4fe3d
https://doi.org/10.1111/j.1365-2036.2006.03235.x
https://doi.org/10.1111/j.1365-2036.2006.03235.x
Publikováno v:
Current medical research and opinion. 25(9)
The primary objective was to assess gastroesophageal reflux disease (GERD) symptom resolution rates with esomeprazole by erosive esophagitis (EE) status, and the secondary objective was to evaluate potential predictors of the presence of EE and heart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec54b4b2203c600b8a3916568f590999
https://pubmed.ncbi.nlm.nih.gov/19601705
https://pubmed.ncbi.nlm.nih.gov/19601705